Esperion Therapeutics, Inc. (ESPR)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
22.88+0.48 (+2.14%)
At close: 4:00PM EDT
22.88 0.00 (0.00%)
After hours: 4:41PM EDT
| Previous close | 22.40 |
| Open | 22.61 |
| Bid | 21.68 x 800 |
| Ask | 22.98 x 800 |
| Day's range | 22.12 - 23.18 |
| 52-week range | 18.01 - 53.73 |
| Volume | 494,063 |
| Avg. volume | 668,609 |
| Market cap | 645.035M |
| Beta (5Y monthly) | 1.17 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -5.77 |
| Earnings date | 09 Aug 2021 - 13 Aug 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 49.27 |
- Simply Wall St.
Analysts Just Slashed Their Esperion Therapeutics, Inc. (NASDAQ:ESPR) EPS Numbers
The latest analyst coverage could presage a bad day for Esperion Therapeutics, Inc. ( NASDAQ:ESPR ), with the analysts...
- Motley Fool
Why Esperion Therapeutics Plummeted Nearly 22% Today
Esperion Therapeutics (NASDAQ: ESPR) widely missed on its first-quarter results. In Q1 Esperion earned $8 million, over four times the $1.8 million of Q1 2020, fueled by $6.4 million in product revenue (royalty revenue came in at roughly $600,000).
- Zacks
Esperion (ESPR) Q1 Earnings Miss, Lower Drug Price Hits Sales
Esperion Therapeutics (ESPR) reports dismal first-quarter results as it misses estimates for earnings and sales. Stock down.
© 2021 Verizon Media. All rights reserved.
